{
    "nctId": "NCT04424732",
    "briefTitle": "SBRT for Breast Cancer Oligometastases",
    "officialTitle": "Stereotactic Body Radiotherapy for Bone Only Oligometastatic Breast Cancer: A Prospective Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasm Malignant Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Progression free survival (PFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women \\>18 years old with a pathologically proven breast cancer who present with 1-3 bone metastases will be included.\n* Metastases need to be confirmed pathologically if possible, otherwise two different imaging modalities (CTor MRI and bone scan or PET) are needed to confirm metastases.\n* Patients should be able to receive the recommended local and systemic treatment and the primary tumor must be controlled at time of SBRT.\n* Maximum diameter of individual metastasis metastasis in any dimension \u2264 5 cm; and must be \\>5 cm away from each other (defined as Edge to Edge of tumor).\n\nExclusion Criteria:\n\n* Non bone metastatic breast cancers\n* Prior history of radiotherapy to same sites of SBRT\n* Pathologic fractures of involved bones\n* Contraindications to radiotherapy including pregnancy and connective tissue disease.\n* Patients with impaired cognitive functions.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}